Fred Schwarzer
2021
In 2021, Fred Schwarzer earned a total compensation of $9.9M as Chief Executive Officer, President and Director at IGM Biosciences, a 94% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $328,900 |
|---|---|
| Option Awards | $8,353,463 |
| Salary | $598,001 |
| Stock Awards | $599,900 |
| Total | $9,880,263 |
Schwarzer received $8.4M in option awards, accounting for 85% of the total pay in 2021.
Schwarzer also received $328.9K in non-equity incentive plan, $598K in salary and $599.9K in stock awards.
Rankings
In 2021, Fred Schwarzer's compensation ranked 1,059th out of 12,415 executives tracked by ExecPay. In other words, Schwarzer earned more than 91.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,059 out of 12,415 | 92nd |
Division Manufacturing | 360 out of 5,508 | 94th |
Major group Chemicals And Allied Products | 127 out of 2,378 | 95th |
Industry group Drugs | 107 out of 2,099 | 95th |
Industry Pharmaceutical Preparations | 73 out of 1,549 | 95th |
Source: SEC filing on April 27, 2022.
Schwarzer's colleagues
We found three more compensation records of executives who worked with Fred Schwarzer at IGM Biosciences in 2021.
News
IGM Biosciences CEO Fred Schwarzer's 2022 pay falls 46% to $5.3M
April 27, 2023
IGM Biosciences CEO Fred Schwarzer's 2021 pay jumps 94% to $9.9M
April 27, 2022
IGM Biosciences CEO Fred Schwarzer's 2020 pay jumps 574% to $5.1M
April 29, 2021
IGM Biosciences CEO Fred Schwarzer's 2019 pay jumps 46% to $757K
April 21, 2020